Ezetimibe

MSD INTL GMBH

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Singapore Flag Singapore

Post An Enquiry

Virtual Booth

Supporting Information : Click here to upload a PDF

US Patent Number

7612058

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-10-30

Patent Use Code

U-1173

Delist Requested

Application Number

21445

Patent Use Description

TO REDUCE ELEVATED TOTAL-C, LDL-C, APO B AND NON-HDL-C IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE ALONE OR IN COMBINATION

Product Number

1

MSD INTL GMBH

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Singapore Flag Singapore

Post An Enquiry

Virtual Booth

EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

7612058

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-10-30

Patent Use Code

U-1027

Delist Requested

Application Number

21445

Patent Use Description

REDUCTION OF ELEVATED PLASMA STEROL AND/OR STANOL LEVELS IN A MAMMAL

Product Number

1

MSD INTL GMBH

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Singapore Flag Singapore

Post An Enquiry

Virtual Booth

EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

7030106

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2022-01-25

Patent Use Code

Delist Requested

Application Number

21445

Patent Use Description

Product Number

1

MSD INTL GMBH

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Singapore Flag Singapore

Post An Enquiry

Virtual Booth

EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

7030106*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2022-07-25

Patent Use Code

Delist Requested

Application Number

21445

Patent Use Description

Product Number

1

MSD INTL GMBH

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Singapore Flag Singapore

Post An Enquiry

Virtual Booth

EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

7612058*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-04-30

Patent Use Code

Delist Requested

Application Number

21445

Patent Use Description

Product Number

1

ESPERION THERAPS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

BEMPEDOIC ACID; EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

9624152

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-12-23

Patent Use Code

U-2749

Delist Requested

Application Number

211617

Patent Use Description

Product Number

1

ESPERION THERAPS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

BEMPEDOIC ACID; EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

7335799

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-12-03

Patent Use Code

Delist Requested

Application Number

211617

Patent Use Description

Product Number

1

ESPERION THERAPS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

BEMPEDOIC ACID; EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

10118881

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-12-23

Patent Use Code

U-2746

Delist Requested

Application Number

211617

Patent Use Description

Product Number

1

ESPERION THERAPS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

BEMPEDOIC ACID; EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

9000041

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-12-23

Patent Use Code

U-2746

Delist Requested

Application Number

211617

Patent Use Description

Product Number

1

ESPERION THERAPS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

BEMPEDOIC ACID; EZETIMIBE

Supporting Information : Click here to upload a PDF

US Patent Number

8497301

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-12-23

Patent Use Code

U-2746

Delist Requested

Application Number

211617

Patent Use Description

Product Number

Find

Overview of Ezetimibe

Ezetimibe

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

55 API Suppliers

24 USDMF

6 JDMF

10 EU WC

33 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

14 Suppliers

DOSSIERs // Finished Dosage Forms

286 Dossiers

55 FDA Orange Book

76 Europe

22 Canada

51 Australia

1 South Africa

81 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

TABLET;ORAL - 180MG;10MG

TABLET;ORAL - 10MG

TABLET;ORAL - 10MG;10MG

TABLET;ORAL - 10MG;20MG

TABLET;ORAL - 10MG;40MG

TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT SUPPLIERS

Suppliers

36 Kerry

20 Gangwal Chemicals

19 BASF

18 Roquette

13 Microlex e.U

12 Sigachi Industries

10 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Vasa Pharmachem

7 DFE Pharma

7 Seppic

6 Capsugel

5 Ideal Cures Pvt Ltd

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 SPI Pharma

2 The Dow Chemical Company

2 Minakem

1 Rochem International Inc

1 Qianhao Chemical (Hebei) Co., Ltd

1 Kima Chemical

1 Aeon Procare

1 ACG Worldwide

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders

43 Coating Systems & Additives

36 Direct Compression

32 Disintegrants & Superdisintegrants

26 Granulation

25 Controlled & Modified Release

16 Lubricants & Glidants

13 Thickeners and Stabilizers

10 Solubilizers

8 Chewable & Orodispersible Aids

7 Film Formers & Plasticizers

7 Co-Processed Excipients

7 Taste Masking

6 API Stability Enhancers

5 Empty Capsules

4 Vegetarian Capsules

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons